Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share     Successful Annual General Meeting with broad approval of all agenda items Board of Management and Supervisory Board actions ratified with large majority Shareholders resolve dividend payment of EUR 0.88 per share Focus on integrating the Muc [ … ]

Dermapharm Holding SE reports dip in revenue, rise in adjusted consolidated EBITDA and margin   In 2025, consolidated revenue decreases to EUR 1,165.0 million (-1.3%) as projected following phase-out of low-margin products in "Parallel import business" segment Consolidated EBITDA (adjusted) remains within forecast range, at EUR 324.8 million; ye [ … ]